Anteris Technologies Global (AVR) Research & Development (2024 - 2026)
Anteris Technologies Global (AVR) posted quarterly Research & Development of $17.5 million for Q1 2026, up 6.08% year-over-year from $16.5 million in Q1 2025, and down 10.54% quarter-over-quarter from $19.5 million in Q4 2025.
Anteris Technologies Global (AVR) Research & Development (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Research & Development for 3 consecutive years, with $17.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 6.08% year-over-year to $17.5 million; the TTM figure through Mar 2026 stood at $70.1 million (up 24.43% YoY), while the FY2025 annual figure was $69.1 million, up 34.34% from the prior year.
- Research & Development fell to $17.5 million in Q1 2026 per AVR's latest filing, from $19.5 million in the prior quarter.
- Across five years, Research & Development topped out at $19.5 million in Q4 2025 and bottomed at $11.6 million in Q1 2024.
- Historically, Research & Development has averaged $15.3 million across 3 years, with a median of $16.3 million in 2025.
- Annual changes were most pronounced in 2025 — Research & Development soared 46.55% — and 2026, when it increased 6.08%.
- Anteris Technologies Global's Research & Development stood at $13.3 million in 2024, then soared by 46.55% to $19.5 million in 2025, then declined by 10.54% to $17.5 million in 2026.
- Business Quant data shows AVR's Research & Development at $17.5 million in Q1 2026, $19.5 million in Q4 2025, and $16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Anteris Technologies Global | 902.34 Mn | 902.34 Mn | 776,000.00 | 23.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.37 Mn |
| Mar 31, 2026 | 17.46 Mn |
| Dec 31, 2025 | 19.51 Mn |
| Sep 30, 2025 | 16.81 Mn |
| Jun 30, 2025 | 16.34 Mn |
| Mar 31, 2025 | 16.46 Mn |
| Dec 31, 2024 | 13.32 Mn |
| Sep 30, 2024 | 13.95 Mn |
| Jun 30, 2024 | 12.63 Mn |
| Mar 31, 2024 | 11.56 Mn |